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Abstract
Background: There have been few prospective studies examining the utility of routine exercise
treadmill testing (ETT) early after percutaneous coronary intervention (PCI). The objective of this
study was to examine the impact of a routine ETT strategy early after PCI on follow-up cardiac
events and procedures.
Methods: We examined 136 patients who underwent routine ETT at 6 weeks post-PCI in the
ADORE trial. The ETT was classified as positive, indeterminate, or negative. The Duke Treadmill
Score (DTS) was calculated for all patients. Follow-up occurred at 9 months.
Results: ETT results at 6 weeks were: 32 (23.5%) positive, 24 (17.6%) indeterminate and 80
(58.8%) negative. At 9 months, the composite event rate was 21.9% in those with a positive ETT,
20.8% in those with an indeterminate ETT and 12.5% in those with a negative ETT (p = 0.25 positive
vs. negative ETT). The sensitivity of early ETT for predicting clinical events was 41.2%, the
specificity was 73.3%, the positive predictive value was 21.9% and the negative predictive value was
87.5%. At 9 months, the cardiac procedure rate was 18.8% in those with a positive test, 13.0% in
those with an indeterminate test, and 6.3% in those with a negative test (p = 0.07 positive vs.
negative ETT). In a multivariate logistic regression model, coronary stenting during PCI and a ≥ 85%
MPHR achieved were found to be inversely associated with clinical events. However, the DTS did
not independently predict clinical events.
Conclusion: Although the statistical power of the study was limited by the small number of clinical
events (particularly MI and death), the results of this study support the ACC/AHA guidelines that
exercise treadmill testing should not be used routinely after PCI.
Background
Over one million percutaneous coronary interventions
(PCI) are performed worldwide annually. The rate of res-
tenosis is between 30–40% following balloon angioplasty
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and 20–30% following stenting with bare metal stents,
and <10 % with drug-eluting stents [1-4]. Most patients
with restenosis present with stable or unstable angina,
although a significant proportion of patients with resten-
osis are asymptomatic [5-7]. Some physicians routinely
perform exercise treadmill testing (ETT) early after PCI in
order to identify those patients with residual stenoses, to
assess functional capacity, or to identify silent ischemia
[8,9]. However, it is unclear if a routine early ETT strategy
is predictive of clinical events following PCI. Two studies
examining the role of ETT post-PCI suggest that it may
predict events (restenosis) [10,11], although the majority
of observational studies suggest that it does not [12-16].
The current ACC/AHA guidelines for exercise stress testing
suggest that routine screening with ETT early after PCI is
not indicated. However, exercise stress testing may be of
value in high risk patients [17]. Our hypothesis was that a
routine, 6-week ETT is not predictive of clinical events.
Methods
The Aggressive Diagnosis of Restenosis (ADORE) trial was
a prospective, multicenter trial that randomized patients
post-PCI to a strategy of routine functional testing vs. a
selective, symptom-driven functional testing strategy.
Prior to patient enrollment, ethics approval was obtained
from the institutional review boards of all participating
centers. Only patients who were completely revascular-
ized were enrolled. Patients in the routine arm of the trial
underwent an ETT 6 weeks following the index PCI. The
ETT's were performed while the patients were taking their
usual medications, including antianginals. The ETT's were
interpreted by the physician supervising the test, and the
results forwarded to the patients' treating physicians. Clin-
ical follow-up occurred at 9 months following randomiza-
tion. Data on clinical events (unstable angina, myocardial
infarction, death,) and repeat cardiac procedures (coro-
nary angiography, repeat PCI, coronary artery bypass
grafting) during the study period were obtained.
We conducted a post-hoc analysis of the subgroup of
patients that underwent early ETT in the routine arm of
the trial. Of the 176 patients that were randomized to rou-
tine 6-week ETT, 146 (83%) underwent an ETT between 5
and 7 weeks after index PCI, and 136 (93%) had complete
follow-up data available. These 136 patients with com-
plete follow-up data formed the study cohort. The exercise
ECG was regarded as being adequate for diagnosis of car-
diac ischemia if the baseline ECG at rest demonstrated ST
depression < 1 mm, and there was no evidence of left ven-
tricular hypertrophy or a left bundle branch block pattern
[17]. The ETT was performed and interpreted according to
standard criteria and definitions [17,18]. A clinically pos-
itive ETT was defined as the development of angina or
angina-equivalent with exercise. An electrically positive
ETT was defined as ≥ 1 mm ST-segment depression in ≥ 3
consecutive beats persisting ≥ 1 minute into recovery. The
ETT results were classified as positive (clinically or electri-
cally positive), negative (clinically and electrically nega-
tive), or indeterminate (inability to achieve ≥ 85% MPHR
with no ECG changes). In the 3 study groups, we analyzed
clinical outcomes (unstable angina, myocardial infarc-
tion, death) and rates of cardiac procedures (coronary
angiography, repeat PCI, and coronary artery bypass graft
surgery). We also calculated the Duke Treadmill Score
(DTS) for all patients [19,20]. This score is calculated by
the following formula: DTS = exercise time on a standard
Bruce protocol in minutes - 5 × (ST-segment depression in
mm) - 4 × (angina score). The angina score is 0 for no
exercise-induced angina, 1 for non-exercise limiting
angina, and 2 for exercise-limiting angina. If a treadmill
protocol other than the standard Bruce were used, the
exercise time corresponding to the standard Bruce was cal-
culated as follows: exercise time = (METS +2.2)/1.3 [21].
A lower DTS (especially ≤ -10) indicates more severe
ischemia and higher mortality than a higher score.
Data analysis
Continuous data are presented as the mean ± standard
deviation, and dichotomous data are presented as per-
centages. Descriptive analyses examined the baseline clin-
ical and procedural characteristics of patients undergoing
PCI. Statistical analyses used the Fisher's exact test for
dichotomous variables. Using logistic regression, we also
examined baseline characteristics, procedural characteris-
tics, and functional testing results in order to determine




Baseline clinical and procedural characteristics are out-
lined in Table 1. In general, the study patients were mid-
dle-aged men who underwent PCI with stent
implantation for single-vessel coronary artery disease.
Procedural success was high, and low residual stenosis
rates were observed. Differences in baseline clinical and
procedural characteristics were observed between the 3
groups of patients. Those in the positive ETT group were
older, had a higher proportion of women, and were more
likely to have multi-vessel coronary artery disease than
those with an indeterminate or negative ETT. Patients
with a positive ETT were also less likely to be diabetic.
Six-week exercise treadmill test
Most patients had the ETT while on antianginal medica-
tions, including beta-blockers. The baseline ECG was nor-
mal in most patients, and was adequate for the diagnosis
of ischemia in >80% of the patients. Among the 136
patients, 32 (23.5%) patients had a positive ETT (develop-
ment of exertional angina in 56.3% and reversibleBMC Cardiovascular Disorders 2007, 7:12 http://www.biomedcentral.com/1471-2261/7/12
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ischemia as noted by ECG changes in 87.5% of patients),
24 (17.6%) had an indeterminate ETT, and 80 (58.8%)
had a negative ETT. A number of patients in each of the 3
groups did not reach ≥ 85% of their maximal age-pre-
dicted heart rate (MPHR, defined as 220-age). However,
most patients achieved a good cardiac workload, reaching
a MET level ≥ 6.0 and a Rate-Pressure Product ≥ 20,000.
The Duke Treadmill Score was lower in those patients
with positive and indeterminate ETT's, compared with
those with a negative ETT [Table 2].
Clinical events and cardiac procedures
The rates of clinical events and cardiac procedures are
listed in Table 3. The majority of events were due to unsta-
ble angina. There was no difference in the composite
event rate between the groups with a positive vs. negative
ETT. There was a trend toward a higher rate of repeat car-
diac procedures (coronary angiography, repeat PCI, or
CABG) after the index PCI in the group with a positive ETT
compared with those with a negative ETT, with a two-fold
difference in procedure rates (p = 0.07 positive vs. nega-
tive ETT). There was no statistically significant difference
in event rates between the positive and indeterminate ETT
groups combined and the negative ETT group.
Test characteristics of a 6-week ETT
Excluding those patients with an indeterminate ETT, the
sensitivity of a routine early ETT at predicting clinical
events was 41.2%, the specificity was 73.7%, the positive
predictive value was 21.9% and the negative predictive
value was 87.5%. If the positive and indeterminate ETT
groups were combined, the sensitivity of the ETT
improved to 54.5%, but specificity decreased to 61.4%.
The positive predictive value decreased slightly to 21.6%,
and there was no change in the negative predictive value.
Univariate and multivariate regression analyses
By univariate analysis, several variables were correlated
with the occurrence of clinical events [Table 4]. However,
when these variables were tested in a multivariate logistic
regression model, only coronary stenting during PCI and
a ≥ 85% MPHR achieved were found to be inversely asso-
ciated with clinical events. The maximum cardiac work-
load (MET level) achieved, the Rate-Pressure product, and
the Duke Treadmill Score did not correlate with clinical
events in our regression model.
Discussion
The objective of our study was to examine the impact of
routine early ETT on follow-up cardiac events and proce-
dures. We hypothesized that a routine, 6-week ETT follow-
ing PCI is not predictive of clinical events, and that a
Table 1: Baseline Clinical and Procedural Characteristics
Positive (N = 32) Indeterminate (N = 24) Negative (N = 80)
Clinical Characteristics
Age (Years ± S.D.) 63.0 ± 8.5 55.1 ± 9.1 56.0 ± 11.0
Male (%) 75.0 87.5 88.6
% LVEF (Mean ± S.D.) 51 ± 12 54 ± 10 55 ± 11
Pre-PCI 3 vessel CAD (%) 18.8 4.2 6.6
Pre-PCI CCS Class III-IV (%) 65.6 29.2 52.5
Current Smoker (%) 50.0 66.7 63.3
Hyperlipidemia (%) 68.8 77.3 67.9
Diabetes Mellitus (%) 12.5 25.0 20.5
Hypertension (%) 62.5 62.5 48.7
Procedural Characteristics
Single-vessel PCI (%) 81.3 100 88.8
Stent inserted (%) 87.5 75.0 86.3
Lesion location (%)
Left anterior descending 50.0 58.3 40.0
Left circumflex 18.7 20.8 17.5
Right coronary 31.3 20.8 42.5
ACC/AHA lesion class B2/C* (%) 61.3 73.9 45.7
Post-PCI TIMI-3 flow (%)* 90.6 100 98.7
% Diameter Stenoses (mean ± S.D.)
% Pre-PCI 86 ± 13 86 ± 12 88 ± 12
% Post-PCI 7 ± 13 5 ± 7 4 ± 10
SD – Standard Deviation; CCS – Canadian Cardiovascular Society; MI – Myocardial Infarction; CABG – Coronary artery Bypass Graft Surgery; PCI 
– Percutaneous Coronary Intervention; LVEF – Left Ventricular Ejection Fraction; CAD – Coronary Artery Disease; TIMI – Thrombolysis In 
Myocardial Infarction; ACC/AHA – American College of Cardiology/American Heart Association; PCI – Percutaneous Coronary Intervention
* If >1 lesion underwent PCI, refers to the first lesion that was treated.BMC Cardiovascular Disorders 2007, 7:12 http://www.biomedcentral.com/1471-2261/7/12
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positive ETT would result in a higher rate of repeat cardiac
procedures. We found that an early ETT was poorly predic-
tive of clinical events, with a positive predictive value of
only 21.9%. The composite endpoint of clinical events
included diagnoses of unstable angina, MI, or death.
Because the diagnosis of unstable angina does not neces-
sarily correlate with long term consequences, we consid-
ered this diagnosis to be a soft endpoint. Since the
composite endpoint of clinical events was largely driven
by the diagnosis of unstable angina, we believe that early
ETT is a poorer predictor of hard endpoints of MI and
death. We also found that a positive ETT result may be
associated with a higher rate of repeat cardiac procedures.
In contrast, the high negative predictive value for ETT
observed in our analysis (87.5%) reflects the low rate of
clinical events in our study group. These results suggest
Table 3: Clinical Events and Cardiac Procedures at 9-months
Positive ETT (N = 32) Indeterminate ETT (N = 24) Negative ETT (N = 80) P-value*
Death N (%) 0 (0.0) 1 (4.2) 1 (1.3) >0.99
Myocardial Infarction N (%) 0 (0.0) 1 (4.2) 2 (2.5) >0.99
Unstable Angina N (%) 7 (21.9) 3 (13.0) 9 (11.3) 0.23
Composite Clinical Events N (%) 7 (21.9) 5 (20.8) 12 (15.0) 0.25
Repeat Angiography N(%) 6 (18.8) 3 (12.5) 5 (6.3) 0.07
Repeat PCI N (%) 4 (12.5) 2 (8.3) 2 (2.6) 0.06
CABG N (%) 1 (3.1) 1 (4.2) 0 (0.0) 0.29
Composite Cardiac Procedures N(%) 11 (34.4) 6 (25.0) 7 (8.8) ≤ 0.01
PCI – Percutaneous Coronary Intervention
CABG – Coronary Artery Bypass Graft Surgery
* P-value for Positive vs. Negative ETT results
Table 2: Six-week ETT results
Positive ETT (N = 32) Indeterminate ETT (N = 24) Negative ETT (N = 80)
Weeks after index PCI (Mean ± S.D.) 6.6 ± 2.9 7.1 ± 2.5 6.4 ± 1.8
% Patients on anti-anginals* 90.3 95.8 82.3
Beta-blockers 80.6 87.5 77.2
Calcium-channel blockers 22.5 33.3 23.1
Long-acting nitrates 25.0 25.0 23.1
Baseline ECG (%)
Normal 54.8 50.0 59.1
Non-specific ST-T abnormalities 12.9 12.5 7.6
Previous MI† 25.8 29.2 22.7
LBBB 3.2 4.2 0.0
RBBB 0.0 4.2 6.1
LVH 3.2 0.0 3.0
Adequate for diagnosis of ischemia‡ 87.1 83.3 95.5
% MPHR achieved (Mean ± S.D.) 88.0 ± 17.4 91.1 ± 26.6 92.0 ± 18.0
% achieving ≥ 85% MPHR 65.6 50.0 72.5
Number of METS achieved (Mean ± S.D.) 8.4 ± 2.5 9.5 ± 3.6 9.5 ± 2.9
Rate-Pressure Product (Mean ± S.D.) 23,936 ± 5,934 23,683 ± 5,612 25,247 ± 6,623
Duke Treadmill Score 0.7 ± 5.0 5.5 ± 4.3 7.8 ± 3.7
Development of exertional angina:
Yes 56.3 0.0 0.0
No 37.5 66.7 100
Indeterminate 6.2 33.3 0.0
Reversible ischemia by ECG:
Yes 87.5 0.0 0.0
No 9.4 12.5 100
Indeterminate 3.1 87.5 0.0
SD – Standard Deviation; METS – Metabolic Equivalents; PCI – Percutaneous Coronary Intervention MPHR – Maximum Predicted Heart Rate; MI – 
Myocardial Infarction; LVH – Left Ventricular Hypertrophy; LBBB – Left Bundle Branch Block; RBBB – Right Bundle Branch Block
* Patients prescribed calcium channel blockers, beta blockers or long-acting nitrates on discharge following index PCI.
† Either Q-wave or Non-Q wave
‡ Patients with ST-depression <1.0 mm on the resting ECG without LVH or LBBBBMC Cardiovascular Disorders 2007, 7:12 http://www.biomedcentral.com/1471-2261/7/12
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that an ETT early after PCI is of little clinical utility, and
they support the current guidelines of the ACC/AHA on
functional testing after PCI [17]. However, definitive con-
clusions cannot be drawn from our study due to the rela-
tively small numbers of patients and clinical events.
In an effort to identify patients with significant residual
stenoses and to assess functional capacity post-revascular-
ization, some physicians perform ETT early (< 2 months)
after PCI [8,9,15]. The results of a few observational stud-
ies examining the utility of an ETT in asymptomatic
patients do not support the practice of routine ETT follow-
ing PCI [12-16]. The current ACC/AHA guidelines for
exercise stress testing post-PCI do not advocate routine
screening ETT for the detection of restenosis in all
patients. However, they conclude that there are insuffi-
cient data to support either a routine or a selective ETT
strategy, especially in patients at a high risk of restenosis
[17].
The results of our study are in keeping with other studies
investigating the utility of an early ETT at predicting angi-
ographic restenosis [23-25]. In these studies, the sensitiv-
ity of the ETT at predicting restenosis ranged between 59–
83% and the specificity between 32–66%. The positive
predictive value was also poor (44–59%). However, these
were observational studies and they did not investigate
clinical end points. In contrast with other studies examin-
ing this issue, our study examined clinical event rates in
patients from a cohort randomized to undergo a routine
early ETT as part of the ADORE trial, and the impact of
such an ETT on follow-up cardiac procedures, thereby lim-
iting a possible selection bias.
The poor sensitivity of an early ETT at predicting resteno-
sis and clinical events is due to several factors. Given that
a majority of patients in our study underwent coronary
stenting, it is unlikely that a significant degree of resteno-
sis will have occurred prior to 6 weeks following PCI;
thereby making ETT an unessential exam in the follow-up
period of post-stent implantation. ETT is also thought to
have a lower sensitivity for the detection of ischemia
involving the territory of a single coronary vessel, com-
pared with multi-vessel CAD [21]. Angina post-PCI is also
an insensitive marker of restenosis as up to 50% of
patients have cardiac ischemia that is clinically silent [5-
7]. An early ETT also has a low specificity at identifying
patients at a higher risk of restenosis primarily due to ST-
segment shifts with exercise unrelated to ischemia. It has
been demonstrated that ST-segment changes with exercise
may persist following successful PCI, and is not always
correlated with restenosis [14]. Spasm of small coronary
vessels may be responsible for these electrically positive
tests in the absence of angiographic restenosis, although
the exact mechanism has yet to be elucidated [26].
In order to increase the diagnostic accuracy of the ETT,
several authors have published novel predictors of resten-
osis. An increase in the ΔST/ΔHR index on serial ETT's
appears to significantly improve the diagnostic accuracy
of an ETT following balloon angioplasty for single vessel
coronary artery disease [23]. Other possible predictors of
restenosis of an early ETT have also been identified
[24,25,27]. However, the diagnostic accuracy for resteno-
sis of these novel predictors has not been extensively
investigated, and their calculation remains technically dif-
ficult.
Table 4: Univariate and multivariate regression analyses – variables predictive of clinical events
Odds Ratio 95% CI P-value
Univariate Analysis
Diabetes 3.25 1.18–8.96 0.02
PCI of LCx 2.49 0.89–6.96 0.08
% Residual Stenosis 1.07 1.02–1.11 0.002
Duke Treadmill Score 0.92 0.84–1.01 0.077
METS achieved 0.85 0.71–1.01 0.057
Stenting 0.19 0.07–0.52 0.001
≥ 85% MPHR achieved 0.17 0.06–0.45 0.0004
Positive ETT 1.66 0.61–4.5 0.32
Negative ETT 0.52 0.21–1.32 0.16
Multivariate Analysis
Stenting 0.15 0.047–0.479 0.0014
≥ 85% MPHR achieved 0.14 0.048–0.417 0.0004
CI – Confidence Interval
LCx – Left Circumflex
MPHR – Maximum Predicted Heart RateBMC Cardiovascular Disorders 2007, 7:12 http://www.biomedcentral.com/1471-2261/7/12
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Our study also raises important questions about the util-
ity of an early ETT following PCI. By multivariate logistic
regression modeling we demonstrated an association
between <85% MPHR achieved with composite clinical
events in our study. Our analysis shows that inability to
achieve ≥ 85% of the MPHR on an ETT after complete cor-
onary revascularization is an independent predictor of
clinical events. To our knowledge, this is the first report of
prognostic utility of a 6-week ETT following PCI for stable
CAD. We feel that ability to achieve this target heart rate is
a surrogate marker of exercise capacity as measured by the
MET level achieved. This finding is in general agreement
with other studies that have shown independent prognos-
tic value of exercise capacity (as measured by the MET
level achieved and the RPP) in other groups of patients
[28-32]. Our finding is also in agreement with a recent
study demonstrating a two-fold higher mortality rate in
asymptomatic women who failed to achieve ≥ 85% of
their age-predicted MPHR [33]. However, the maximum
MET level achieved and the Rate-Pressure Product did not
correlate with clinical events in our study. This may have
been due to the low event rate observed and a low propor-
tion of patients with multi-vessel CAD in our study. An
early ETT following PCI may help physicians identify this
subgroup of patients with a poor exercise capacity with a
higher risk of future coronary events. Early ETT may also
be of value to assess a patient's exercise capacity with
regard to rehabilitation and their return to the workforce.
These patients, similar to other patients with obstructive
CAD, may benefit from aggressive modification of risk
factors for CAD with behavioral changes and medical
therapy.
Limitations
There are several limitations to this study. First, the rela-
tively small number of patients and clinical events limits
the statistical power of our analysis, and increases the like-
lihood of a type II (beta) error. Second, the lack of a stand-
ardized protocol for performing the ETT in our study may
have lead to inter-operator variability. However, our
intention was to provide a snapshot of real world practice
within the setting of a clinical trial. Third, the continua-
tion of beta blockers could lower maximum heart rate,
thus confusing this variable. Finally, antianginal therapy
was not stopped routinely prior to ETT, which may have
delayed the time to the onset of cardiac ischemia. Since all
patients enrolled in the ADORE trial were completely
revascularized, and most patients achieved an excellent
cardiac workload, this is unlikely to have had a significant
impact on the ETT results.
Conclusion
Our study was designed to examine differences in clinical
outcome and repeat cardiac procedure rates in patients
undergoing routine ETT 6 weeks after PCI. We found that
there did not appear to be a significant difference in clini-
cal events between those with a positive ETT compared
with those with a negative ETT, although definitive con-
clusions cannot not be drawn due to limited statistical
power. An early ETT also appears to be poorly predictive
of clinical events and, a positive ETT result may lead to a
higher rate of repeat cardiac procedures. These results sug-
gest that a routine early ETT following PCI has little clini-
cal utility, and support the current consensus guidelines of
the ACC/AHA that routine exercise treadmill testing early
after PCI is not predictive of subsequent clinical events.
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